Senior insider sale
Ch. Operating & Financial Off. at OLEMA PHARMACEUTICALS, INC. — senior position signals high conviction
$8.35M
432.34K shares
KOVACS SHANE WILLIAM CHARLES plans to sell 432.34K shares of OLEMA PHARMACEUTICALS, INC. valued at approximately $8.35M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Option Granted 02/01/2022
Cash
Option Granted 02/28/2025
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/9/2026 | Option Granted 02/01/2022 Cash | 162K | — |
3/9/2026 | Option Granted 02/28/2025 Cash | 80K | — |
| Total | 242K | ||
Completed
Units to sell
20K
Market value
$488.7K
Units to sell
6.52K
Market value
$163.0K
Units to sell
20K
Market value
$500.0K
Units to sell
30K
Market value
$723.0K
Units to sell
10K
Market value
$238.5K
Units to sell
100K
Market value
$2.87M
Units to sell
3.82K
Market value
$107.1K
Planned — Approximate Date
Units to sell
242K
Market value
$3.25M
Units
432.34K
Value
$8.35M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/4/2026 | 20K | $488.7K | — | Completed |
2/27/2026 | 6.52K | $163.0K | — | Completed |
2/24/2026 | 20K | $500.0K | — | Completed |
2/23/2026 | 30K | $723.0K | — | Completed |
2/12/2026 | 10K | $238.5K | — | Completed |
1/15/2026 | 100K | $2.87M | — | Completed |
1/13/2026 | 3.82K | $107.1K | — | Completed |
| Planned — Approximate Date | ||||
3/9/2026 | 242K | $3.25M | NASDAQ | Planned |
| Total | 432.34K | $8.35M | ||